World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
94
Citations
37170
World Ranking
560
National Ranking
261

Medicine

D-Index
94
Citations
37492
World Ranking
10379
National Ranking
5342

Research.com Recognitions

  • 2001 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

William G. Powderly is affiliated with Washington University in St. Louis in the United States. Their research primarily spans the field of Medicine, with a strong focus on Infectious Diseases, Epidemiology, Neurology, Emergency Medicine, and Oncology.

The scientist's recent papers include:

  • Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm (2020, Science Advances)
  • The post-antibiotic era is here (2021, Science)
  • The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era (2022, Clinical Infectious Diseases)
  • Integrase Strand Transfer Inhibitors Are Associated With Incident Diabetes Mellitus in People With Human Immunodeficiency Virus (2022, Clinical Infectious Diseases)
  • Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia (2023, JAMA)

The scientist frequently publishes in these venues:

  • Open Forum Infectious Diseases
  • UNC Libraries
  • Clinical Infectious Diseases
  • International Journal of Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)

Main topics of their work comprise:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Fungal Infections and Studies
  • Antifungal resistance and susceptibility
  • Long-Term Effects of COVID-19
  • HIV-related health complications and treatments
  • Antibiotic Use and Resistance

Frequent co-authors of William G. Powderly include:

  • Andrej Spec
  • Jane A. O'Halloran
  • Adriana M. Rauseo
  • Margaret A. Olsen
  • Lindsey Larson

William G. Powderly was awarded the Fellow of the American Association for the Advancement of Science (AAAS) in 2001.

Best Publications

  • Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

    John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman

  • Practice Guidelines for the Management of Cryptococcal Disease

    Michael S. Saag;Richard J. Graybill;Robert A. Larsen;Peter G. Pappas

  • A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

    Jesse L. Goodman;Drew J. Winston;Ronald A. Greenfield;Pranatharthi H. Chandrasekar

  • A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

    Peter G. Pappas;John H. Rex;Jeannette Lee;Richard J. Hamill

  • Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

    van der Horst Cm;Saag Ms;Cloud Ga;Hamill Rj

  • Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

    Sharon A. Riddler;Richard Haubrich;A. Gregory DiRienzo;Lynne Peeples

  • The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial

    M. A. Fischl;D. D. Richman;N. Hansen;A. C. Collier

  • Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis

    M S Saag;W G Powderly;G A Cloud;P Robinson

  • Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

    Andrew R. Zolopa;Janet Andersen;Lauren Komarow;Ian Sanne

  • Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

    Pablo Tebas;William G. Powderly;Sherry Claxton;Donna Marin

  • Amphotericin B: current understanding of mechanisms of action.

    J Brajtburg;W G Powderly;G S Kobayashi;G Medoff

  • Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

    Luis Ostrosky-Zeichner;John H. Rex;Peter G. Pappas;Richard J. Hamill

  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

    David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg

  • Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis

    J R Graybill;J Sobel;M Saag;C van Der Horst

  • A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection

    Markowitz M;Saag M;Powderly Wg;Hurley Am

  • Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

    Morris Schambelan;Constance A. Benson;Andrew Carr;Judith S. Currier

  • A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

    W D Hardy;J Feinberg;D M Finkelstein;M E Power

  • A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.

    W G Powderly;M S Saag;M S Saag;G A Cloud;G A Cloud;P Robinson;P Robinson

  • A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection.

    S. A. Bozzette;D. M. Finkelstein;S. A. Spector;P. Frame

  • Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS

    Philip C. Johnson;L. Joseph Wheat;Gretchen A. Cloud;Mitchell Goldman

  • A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

    William G. Powderly;Dianne M. Finkelstein;Judith Feinberg;Peter Frame

Frequent Co-Authors

Pablo Tebas
Pablo Tebas University of Pennsylvania
Kevin E. Yarasheski
Kevin E. Yarasheski Washington University in St. Louis
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
Margaret A. Fischl
Margaret A. Fischl University of Miami
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
William E. Dismukes
William E. Dismukes University of Alabama at Birmingham
Robert L. Murphy
Robert L. Murphy Northwestern University
Gregory A. Storch
Gregory A. Storch Washington University in St. Louis
Richard J. Hamill
Richard J. Hamill Baylor College of Medicine
Victoria J. Fraser
Victoria J. Fraser Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to diverse career options in healthcare, research, and beyond. For those interested in advancing their education, pursuing online public health masters programs easy to get into can be a strategic choice. These programs offer flexibility and accessibility for microbiology graduates seeking to expand their impact on community health.

Career pathways also extend to specialized roles such as a child life specialists salary reveals a promising outlook, especially for those passionate about supporting children’s health and development. This profession often benefits from a background in life sciences, including microbiology.

For individuals with unique challenges, it's encouraging to know there are degrees felons can get that maintain career viability in the sciences and health sectors. Online programs in microbiology and related fields can offer a pathway to rebuilding and growth.

Another growing field is functional medicine, where professionals like nurse practitioners earn competitive wages, highlighted by the functional medicine np salary. Combining microbiology knowledge with clinical practice can enhance career diversity and opportunities.

Best Scientists Citing William G. Powderly

Trending Scientists

Recently Published Articles